TY - JOUR
T1 - International assessment of the link between COVID-19 related attitudes, concerns and behaviours in relation to public health policies
T2 - Optimising policy strategies to improve health, economic and quality of life outcomes (the iCARE Study)
AU - Bacon, Simon L.
AU - Lavoie, Kim L.
AU - Boyle, Jacqueline
AU - Stojanovic, Jovana
AU - Joyal-Desmarais, Keven
N1 - Funding Information:
Funding The primary source of funding for the iCARE study has been primarily through redirected funding associated with Montreal Behavioural Medicine Centre, including funds from a Canadian Institutes of Health Research-Strategy for Patient Oriented Research Mentoring Chair (SMC-151518, PI: SB), a Fonds de Recherche du Québec: Santé Chair (251618, PI: SB), a Université du Québec à Montréal Research Chair (1471, PI: KLL) and Fonds de Recherche du Québec: Santé Senior Research Award (34757, PI: KLL). The Canadian representative sampling will be funded by the Canadian Institutes of Health Research (MS3‐173099, PI: SB) and the Fonds de Recherche du Québec: Société et Culture (2019-SE1-252541, PI: SB). The Australian representative sampling was funded by Monash University and indirectly by the National Health and Medical Research Council and the Medical Research Future Fund (2579, PIs: Drs Helena Teede and JB). The Irish representative sampling was funded by the Health Research Board and the Irish Research Council (COV19-2020-097, PI: Dr Gerard J Molloy). The UK representative sampling was funded by CALIBRE research funding, provided by Loughborough University, UK (5705, PI: Dr Nicola J Paine). None of the funders were involved in the study design.
Publisher Copyright:
© 2021 The Author(s). Published by Cambridge University Press.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/3/11
Y1 - 2021/3/11
N2 - Introduction In the context of a highly contagious virus with only recently approved vaccines and no cure, the key to slowing the spread of the COVID-19 disease and successfully transitioning through the phases of the pandemic, including vaccine uptake, is public adherence to rapidly evolving behaviour-based public health policies. The overall objective of the iCARE Study is to assess public awareness, attitudes, concerns and behavioural responses to COVID-19 public health policies, and their impacts, on people around the world and to link behavioural survey data with policy, mobility and case data to provide behavioural science, data-driven recommendations to governments on how to optimise current policy strategies to reduce the impact of the COVID-19 pandemic. Methods and analyses The iCARE study (www.icarestudy.com) uses a multiple cross-sectional survey design to capture self-reported information on a variety of COVID-19 related variables from individuals around the globe. Survey data are captured using two data capture methods: convenience and representative sampling. These data are then linked to open access data for policies, cases and population movement. Ethics and dissemination The primary ethical approval was obtained from the coordinating site, the Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal (REB#: 2020-2099/03-25-2020). This study will provide high-quality, accelerated and real-Time evidence to help us understand the effectiveness of evolving country-level policies and communication strategies to reduce the spread of the COVID-19. Due to the urgency of the pandemic, results will be disseminated in a variety of ways, including policy briefs, social media posts, press releases and through regular scientific methods.
AB - Introduction In the context of a highly contagious virus with only recently approved vaccines and no cure, the key to slowing the spread of the COVID-19 disease and successfully transitioning through the phases of the pandemic, including vaccine uptake, is public adherence to rapidly evolving behaviour-based public health policies. The overall objective of the iCARE Study is to assess public awareness, attitudes, concerns and behavioural responses to COVID-19 public health policies, and their impacts, on people around the world and to link behavioural survey data with policy, mobility and case data to provide behavioural science, data-driven recommendations to governments on how to optimise current policy strategies to reduce the impact of the COVID-19 pandemic. Methods and analyses The iCARE study (www.icarestudy.com) uses a multiple cross-sectional survey design to capture self-reported information on a variety of COVID-19 related variables from individuals around the globe. Survey data are captured using two data capture methods: convenience and representative sampling. These data are then linked to open access data for policies, cases and population movement. Ethics and dissemination The primary ethical approval was obtained from the coordinating site, the Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal (REB#: 2020-2099/03-25-2020). This study will provide high-quality, accelerated and real-Time evidence to help us understand the effectiveness of evolving country-level policies and communication strategies to reduce the spread of the COVID-19. Due to the urgency of the pandemic, results will be disseminated in a variety of ways, including policy briefs, social media posts, press releases and through regular scientific methods.
KW - COVID-19
KW - health policy
KW - preventive medicine
KW - public health
UR - https://www.scopus.com/pages/publications/85102454763
U2 - 10.1136/bmjopen-2020-046127
DO - 10.1136/bmjopen-2020-046127
M3 - Article
C2 - 33707274
AN - SCOPUS:85102454763
SN - 2044-6055
VL - 11
JO - BMJ Open
JF - BMJ Open
IS - 3
M1 - e046127
ER -